iDOVE: Durability of Vaccine Efficacy Against SARS-CoV-2 Infection

Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021) <doi:10.1093/cid/ciab630>.

Version: 1.3
Depends: R (≥ 3.5.0)
Imports: Rcpp (≥, methods, stats, graphics, knitr
LinkingTo: Rcpp, RcppArmadillo
Suggests: rmarkdown
Published: 2021-09-15
Author: Yu Gu [aut], Shannon T. Holloway [aut, cre], Dan-Yu Lin [aut]
Maintainer: Shannon T. Holloway <sthollow at>
License: GPL-2
NeedsCompilation: yes
Materials: NEWS
CRAN checks: iDOVE results


Reference manual: iDOVE.pdf
Vignettes: iDOVE-vignette


Package source: iDOVE_1.3.tar.gz
Windows binaries: r-devel:, r-devel-UCRT:, r-release:, r-oldrel:
macOS binaries: r-release (arm64): iDOVE_1.3.tgz, r-release (x86_64): iDOVE_1.3.tgz, r-oldrel: iDOVE_1.3.tgz


Please use the canonical form to link to this page.